This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
PDA Technical Report No. 73 (TR 73) Prefilled Syringe User Requirements for Biotechnology Applications discusses the requirements for the 1 mL long glass prefilled syringe (PFS) for biotechnology applications.
Over the past decade, a large number of subcutaneously injected biotechnology drug products have been packaged in PFSs because of the benefits compared to vials or ampules. The benefits of PFSs include reduction of medical dosing errors, reduction in risk of microbial contamination by decreased manipulation prior to injection, and improved compliance due to ease of use. In addition to the patient benefits, PFSs often have lower overfill regulatory requirements than vials, thereby reducing product waste.
This report provides guidance on material selection and evaluation for suitability, syringe preparation and handling (including human factors), and drug product compatibility (physical and chemical) with the syringe materials and mode of delivery. Plastic syringes and ancillary devices, such as autoinjectors, are not within scope.
As a non-member of PDA, you can purchase this trending document for $325. Or, you can join PDA by Nov. 30, 2015 for only $259 and download your personal digital copy for FREE! And, when you become a PDA member, you will gain on-demand access to view the entire online library of more than 65 peer-reviewed Technical Reports – valued at more than $10,000.
This is an opportunity you can’t afford to pass up – join PDA for less than the non-member price of a single Technical Report and gain access to all Technical Reports as well as a wealth of other members-only benefits! Be sure to join by Nov. 30, 2015 to gain FREE access to the Prefilled Syringe User Requirements for Biotechnology Applications Technical Report!
For more information, click here
